The cell line is not submitted yet.
(only basic data is shown)
General
Cell Line |
|
| hPSCreg name | SCTi004-A |
| Cite as: | SCTi004-A |
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines | No similar lines found. |
| Last update | 22nd February 2024 |
| Notes | The Healthy Control Human iPSC Line, Male, SCTi004-A from STEMCELL Technologies (Cat no. #200-0769) was derived from peripheral blood mononuclear cells (PBMCs) from a 23-year-old donor. Extensive quality control procedures were undertaken in the iPSC manufacturing process to ensure optimal product performance and reproducibility. SCTi004-A is karyotypically stable, demonstrates trilineage differentiation potential, expresses markers of the undifferentiated state, and was reprogrammed using a non-integrating reprogramming technology. The cell line may be used as a healthy control for a multitude of pluripotent stem cell research applications including downstream differentiation to lineage-specific cell types and organoids. SCTi004-A is manufactured with mTeSR™ Plus and is fully compatible with STEMdiff™ cell culture media products, allowing for standardized high-quality maintenance and differentiation to various cell types such as cardiomyocytes, neurons, astrocytes, and microglia. |
| User feedback | |
Provider |
|
| Generator |
STEMCELL Technologies Inc. (SCT)
Contact:
STEMCELL Technologies Inc. (SCT) |
| Owner | STEMCELL Technologies Inc. (SCT) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA115048409 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
Additional restrictions:
For in vitro research use only. Not approved for diagnostic, therapeutic, or clinical applications. Not approved for human or veterinary use in vivo. |
hIPSC Derivation
General |
Login to share your feedback, experiences or results with the research community.